Clinical Trial: Feasibility of Radiofrequency Ablation in the Management of Papillary Thyroid Cancer Under Ultra-Sound Guidance.
Study Status: Recruiting
Recruit Status: Unknown status
Study Type: Interventional
Official Title: Feasibility of Radio-Frequency Ablation in the Management of Papillary Thyroid Cancer Under Ultra-Sound Guidance
Brief Summary: To study the feasibility of Radiofrequency ablation (RFA) via ultrasound guidance in the treatment of papillary thyroid cancer (PTC).
Detailed Summary:
Around 23,000 cases of thyroid cancer are discovered annually in the US, and PTC accounts for 70-75% of those cases. The conventional treatment consists mainly of surgical resection, in the form of lobectomy with/without isthmusectomy, or total thyroidectomy, making it one of the most commonly performed procedures. It has high costs, and exposes the patients to morbidity of surgery and anesthesia. PTC tends to be indolent with a 90% cure rate and controversy exists regarding extent of treatment.
Percutaneous image-guided RFA has received increasing attention as a promising minimally invasive technique for the treatment of focal malignant disease. It permits the in situ destruction of tumors without necessitating their surgical excision.
Sponsor: Johns Hopkins University
Current Primary Outcome:
- After the procedure, each patient will have his/her routine post-operative care and the follow up visits for surgery, without additional specified visits or procedures for the study
- Patients will be examined for any possible complications at the time of surgery.
Original Primary Outcome: Same as current
Current Secondary Outcome: Patients will be followed-up accordingly for any complications.
Original Secondary Outcome: Same as current
Information By: Johns Hopkins University
Dates:
Date Received: September 26, 2006
Date Started: November 2006
Date Completion: November 2008
Last Updated: September 26, 2006
Last Verified: September 2006
